CareDx, Inc. (FRA:1K9)

Market Cap	889.63M -24.8%
Revenue (ttm)	305.12M +14.5%
Net Income	60.05M
EPS	1.04
Shares Out	n/a
PE Ratio	14.82
Forward PE	20.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	16
Open	17.07
Previous Close	17.41
Day's Range	17.07 - 17.07
52-Week Range	9.83 - 24.05
Beta	n/a
RSI	53.18
Earnings Date	Feb 27, 2026

About CareDx

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to typ...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 650
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1K9

Financial Performance

Financial numbers in USD